0001179110-14-010047.txt : 20140624
0001179110-14-010047.hdr.sgml : 20140624
20140609204731
ACCESSION NUMBER: 0001179110-14-010047
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140602
FILED AS OF DATE: 20140609
DATE AS OF CHANGE: 20140609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRIEDMAN CATHY
CENTRAL INDEX KEY: 0001411874
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 14900406
MAIL ADDRESS:
STREET 1: C/O XENOPORT, INC.
STREET 2: 3410 CENTRAL EXPRESSWAY
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
4/A
1
edgar.xml
FORM 4/A -
X0306
4/A
2014-06-02
2014-06-04
0
0001080014
THERAVANCE INC
THRX
0001411874
FRIEDMAN CATHY
THERAVANCE, INC.
901 GATEWAY BLVD
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2014-06-02
4
A
0
7585
0
A
7585
D
Common Stock
2014-06-02
4
A
0
7585
0
A
15170
D
Stock Option (Right to Buy)
23.0786
2014-06-02
4
A
0
7585
0
A
2024-06-01
Common Stock
7585
7585
D
Stock Option (Right to Buy)
23.0786
2014-06-02
4
A
0
7585
0
A
2024-06-01
Common Stock
7585
7585
D
The number of shares was adjusted by a factor to account for the effect of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc. The factor was based on the 3-day post-spin volume weighted average price of Theravance, Inc, and Theravance Biopharma, Inc. and the stock dividend of one ordinary share of Theravance Biopharma, Inc. for every 3.5 shares of Theravance, Inc. common stock received by Theravance, Inc. stockholders as of the record date for the spin-off.
This option may be exercised and shall be vested as to 1/24th of the shares subject to this option when optionee completes each continuous month of service following the grant date.
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's stockholders provided the optionee remains in continuous service on such date.
Heather M. Shane, Attorney-in-Fact
2014-06-09